News | Lung Cancer | April 23, 2018

National Cancer Institute Grant Creates National Lung Cancer Screening Center

Joint effort of five health systems will work to improve lung cancer screening and reduce disparities nationwide

National Cancer Institute Grant Creates National Lung Cancer Screening Center

April 23, 2018 — Researchers from the Perelman School of Medicine at the University of Pennsylvania and four other institutions have received a five-year, $15.5 million National Cancer Institute (NCI) grant to improve lung cancer screening. Specifically, the focus will be on improving the effectiveness of screening, and increasing the delivery of screening in populations that experience disparities in early diagnosis, treatment and mortality.

The other grant-receiving institutions include:

  • The Institute for Health Research at Kaiser Permanente Colorado;
  • Kaiser Permanente Hawaii;
  • The Henry Ford Health System in Detroit; and
  • Marshfield Clinic Health System in Wisconsin.

The funding will establish the Center for Research to Optimize Precision Lung Cancer Screening (CPLS), one of three specialized cancer screening research centers under the Population-based Research to Optimize the Screening Process II (PROSPR II) initiative by the Healthcare Delivery Research Program at NCI. The center will develop a shared model data for a lung cancer screening data repository to conduct research on developing and testing ways to prevent underuse, overuse, and misuse of screening for lung cancer nationally.

The new center — co-directed by Chyke Doubeni, M.D., chair of family medicine and community health at the Perelman School of Medicine, and Debra P. Ritzwoller, Ph.D., of Kaiser Permanente — joins scientists from five health systems contributing to the NCI-funded Population-Based Research to Optimize the Screening Process II (PROSPR II) Initiative for lung, colon, and cervical cancer. PROSPR II promotes research focused on evaluating and improving cancer screening.

“Lung cancer disparities present an urgent public health crisis in most communities across the United States,” said Doubeni. “We’ve seen some hope in low-dose computed tomography [CT] screening to reduce the risk of lung cancer and also as an opportunity to promote smoking cessation treatments, but many questions remain about the best way to optimize the delivery of screening in our communities. I look forward to the collaborative work by these diverse institutions to tackle these issues in depth and develop best practices for improving the delivery and effectiveness of screening.”

Lung cancer is the highest cause of cancer deaths in the United States, according to the National Cancer Institute, taking the lives of an estimated 154,050 people annually. When performed in a timely manner, screening can find lung cancer at more treatable stages.

In addition to Doubeni, the interdisciplinary research team at Penn includes Mitchell Schnall, Anil Vachani, Despina Kontos, Katherine Rendle, Jason Roy, Fran Barg and Michael Horst.

For more information: www.med.upenn.edu

 

Related Content

New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...
Example of an intentionally truncated CT image

Figure 1: Example of an intentionally truncated CT image. The truncation percentage was calculated as the ratio of the patient border touching the field of view to the total patient border (red/(read+blue)). Image courtesy of Qaelum.

Feature | Radiation Dose Management | July 15, 2019 | Niki Fitousi, Ph.D., and An Dedulle
One of the main benefits of a radiation dose management system is the possibility to automatically generate alerts when...
Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity.

Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity. UW-Madison was the first site in the U.S. to get this technology. Its use is now being integrated into UW CT protocols. Image courtesy of Timothy P. Szczykutowicz

Feature | Computed Tomography (CT) | July 12, 2019 | By Greg Freiherr
When providers develop their own imaging protocols, they are wasting time and money, according to...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Mednax National Cardiac Centers of Excellence Program Highlighted at SCCT 2019
News | CT Angiography (CTA) | July 11, 2019
Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will...
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Achenbach to Receive Inaugural 2019 Stephan Achenbach Pioneer Award in Cardiovascular CT
News | Cardiac Imaging | July 10, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present Stephan Achenbach, M.D., FSCCT with the inaugural...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...
Jonathon Leipsic Awarded 2019 DeHaan Award for Innovation in Cardiology
News | Cardiac Imaging | July 08, 2019
Jonathon A. Leipsic, M.D., FSCCT, is the recipient of the 2019 DeHaan Award for Innovation in Cardiology, announced by...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...